EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Symmetry Surgical's enterprise value is €270.9 Mil.
Symmetry Surgical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2014 was €18.6 Mil. Therefore, Symmetry Surgical's EV-to-EBITDA for today is 14.56.
The historical rank and industry rank for Symmetry Surgical's EV-to-EBITDA or its related term are showing as below:
FRA:RZV'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 19.31
Current: 19.31
During the past 13 years, the highest EV-to-EBITDA of Symmetry Surgical was 19.31. The lowest was 0.00. And the median was 0.00.
FRA:RZV's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 15.225
vs FRA:RZV: 19.31
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Symmetry Surgical EV-to-EBITDA Historical Data
The historical data trend for Symmetry Surgical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Symmetry Surgical's EV-to-EBITDA
For the Medical Devices subindustry, Symmetry Surgical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Symmetry Surgical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Symmetry Surgical's EV-to-EBITDA falls into.
Symmetry Surgical's current Enterprise Value is €270.9 Mil.
Symmetry Surgical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €18.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Symmetry Surgical's PE Ratio for today is calculated as:
Symmetry Surgical's share price for today is €7.81.
Symmetry Surgical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.122.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Symmetry Surgical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:RZV has been successfully added to your 